Biolex is a clinical-stage biopharmaceutical company that uses their patented LEX SystemSM to develop hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance their efficacy and potency. The LEX System is a technology that genetically transforms the aquatic plant Lemna to enable the production of biologic product candidates. Their main product aims at treating those afflicted with Hepatitis C.
Past Team (3)Update
Funding Rounds (8) - $172.3MUpdate
Mitsui & Co. Global Investment is a venture capital fund that focuses on early stage...
Regional Private Equity
Venture Capital Firm
Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads...
Clarus Ventures is a life sciences venture capital firm.
Venture capital subsidiary
The Dow Company manufactures and sells chemicals, plastic materials, agricultural services and...
OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under...
158 Credle Street
Pittsboro, NC 27312